P.L. van Riel
Impact in
- Rheumatology top 0.2%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Musculoskeletal synovial abnormalities and treatments
- Hematology top 1%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 28
- Rheumatoid Arthritis Research and Therapies 26
- Systemic Lupus Erythematosus Research 7
- Osteoarthritis Treatment and Mechanisms 2
-
- Biosimilars and Bioanalytical Methods 4
- Co-authors
- L B van de Putte (13 shared papers)M. A. van Leeuwen (2 shared papers)M. H. van Rijswijk (2 shared papers)Désirée van der Heijde (1 shared paper)M.A. van ’t Hof (1 shared paper)E. Lubberts (1 shared paper)Peter Tugwell (2 shared papers)Gérard Eberl (1 shared paper)
- Journals
- Annals of the Rheumatic Diseases (12 papers)Lara D. Veeken (6 papers)Scandinavian Journal of Rheumatology (2 papers)PubMed (5 papers)Data Archiving and Networked Services (DANS) (1 paper)
- Partner nations
- NetherlandsUnited KingdomUnited States
In The Last Decade
P.L. van Riel
33 papers receiving 2.4k citations
P.L. van Riel's Hit Papers
Peers
Comparison fields: 5 of 103
- Rheumatology 2.1k
- Hematology 742
- Genetics 243
- Orthopedics and Sports Medicine 173
- Pathology and Forensic Medicine 350
Countries citing papers authored by P.L. van Riel
This map shows the geographic impact of P.L. van Riel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.L. van Riel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.L. van Riel more than expected).
Fields of papers citing papers by P.L. van Riel
This network shows the impact of papers produced by P.L. van Riel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.L. van Riel. The network helps show where P.L. van Riel may publish in the future.
Co-authors
The 25 scholars most cited alongside P.L. van Riel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Hit paper breakdown → | 1990 | 855 |
| 2 | A simplified disease activity index for rheumatoid arthritis for use in clinical practice Hit paper breakdown → | 2003 | 795 |
| 3 | 2014 | 206 | |
| 4 | Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification). | 1995 | 179 |
| 5 | 1993 | 130 | |
| 6 | 1995 | 66 | |
| 7 | 1992 | 62 | |
| 8 | 1999 | 55 | |
| 9 | 2011 | 27 | |
| 10 | 1998 | 23 | |
| 11 | 1995 | 22 | |
| 12 | Influence of a ceiling effect on the assessment of radiographic progression in rheumatoid arthritis during the first 6 years of disease. | 1999 | 21 |
| 13 | Genetic anticipation in rheumatoid arthritis in Europe. European Consortium on Rheumatoid Arthritis Families. | 2001 | 20 |
| 14 | 1999 | 18 | |
| 15 | 2013 | 14 | |
| 16 | Management of refractory rheumatoid arthritis. | 1999 | 7 |
| 17 | The drug survival of adalimumab compared to etanercept and infliximab in treatment of patients with rheumatoid arthritis in daily clinical practice | 2006 | 6 |
| 18 | 1984 | 6 | |
| 19 | 2018 | 6 | |
| 20 | The new ACR / EULAR Definition of Remission in Rheumatoid Arthritis: Is the Patient Global Assessment Criterion too strict? | 2012 | 4 |
About P.L. van Riel
P.L. van Riel is a scholar working on Rheumatology, Immunology, Pathology and Forensic Medicine, Pharmacology and Genetics, having authored 34 papers that have together received 2.5k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (26 papers), Systemic Lupus Erythematosus Research (7 papers), Biosimilars and Bioanalytical Methods (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Peripheral Neuropathies and Disorders (3 papers), Osteoarthritis Treatment and Mechanisms (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). The work is most often cited by research in Rheumatology (2.1k citations), Hematology (742 citations), Genetics (243 citations), Orthopedics and Sports Medicine (173 citations) and Pathology and Forensic Medicine (350 citations). P.L. van Riel has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include L B van de Putte, M. A. van Leeuwen, M. H. van Rijswijk, Désirée van der Heijde, M.A. van ’t Hof, E. Lubberts, Peter Tugwell, Gérard Eberl, Joachim R. Kalden and Paul Emery. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Scandinavian Journal of Rheumatology, PubMed and Data Archiving and Networked Services (DANS).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.